Connor, Clark & Lunn Investment Management (CC&L)
TARO

Connor, Clark & Lunn Investment Management (CC&L)’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-14,367
Closed -$600K – 1744
2023
Q4 		$600K Buy
14,367
+3,034
+27% +$112K ﹤0.01% 993
2023
Q3 		$427K Buy
+11,333
New +$425K ﹤0.01% 1057
2020
Q3 		– Sell
-5,623
Closed -$374K – 1164
2020
Q2 		$374K Sell
5,623
-652
-10% -$43.7K ﹤0.01% 805
2020
Q1 		$384K Buy
6,275
+500
+9% +$37K ﹤0.01% 754
2019
Q4 		$508K Sell
5,775
-1,700
-23% -$143K ﹤0.01% 660
2019
Q3 		$564K Buy
7,475
+1,175
+19% +$95.4K ﹤0.01% 658
2019
Q2 		$538K Sell
6,300
-650
-9% -$64.3K ﹤0.01% 709
2019
Q1 		$751K Sell
6,950
-2,575
-27% -$256K 0.01% 587
2018
Q4 		$806K Sell
9,525
-3,900
-29% -$376K 0.01% 593
2018
Q3 		$1.32M Buy
13,425
+675
+5% +$73K 0.01% 524
2018
Q2 		$1.48M Buy
+12,750
New +$1.4M 0.01% 536
2016
Q3 		– Sell
-5,100
Closed -$743K – 928
2016
Q2 		$743K Buy
+5,100
New +$723K 0.01% 514

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s TARO Position: Q1 2024 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2024, closing a stake of 14,367 shares — an estimated $600K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in TARO in Q2 2016 and held it in 12 quarters. The position peaked at $1.48M in Q2 2018. 94 funds tracked by Wall St. Rank hold TARO as of Q1 2024.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2024 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 14,367 Taro Pharmaceutical Industries Ltd. shares in Q1 2024, an estimated $600K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2016 and held it in 12 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Taro Pharmaceutical Industries Ltd. position peaked at $1.48M in Q2 2018.
  • 94 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2024.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2024, filed 9 May 2024.